StockDrifts LogoStockDrifts

Genotech 066830

Company
제노텍Genotech
Insiders
1
Buys
1
Total Value
₩8M ($6K)
Avg Return
-39.61%
Last Filing
2026-02-02

Genotech (066830) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩8M ($6K) in reported transaction value. The earliest filing StockDrifts holds for Genotech is dated 2024-03-08; the most recent is 2026-02-02. Across these filings the average return since disclosure is -39.61%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-02-02BUY신규선임
이인재
Injae Lee
moving10.5K₩975+5.2%₩10M ($7K)
2025-03-24SELL임원퇴임
백승우
Seungwoo Baek
Internal director-16.8K₩1,397+26.6%₩23M ($16K)
2024-08-09BUY시간외매매
김재종
Jaejong Kim
CEO100.0K₩1,486-31.0%₩149M ($103K)
2024-03-08BUYMarket Buy
김재종
Jaejong Kim
CEO5.0K₩1,699-39.6%₩8M ($6K)

Frequently asked questions

Who has been buying Genotech stock?
1 distinct insiders have filed 1 disclosed insider purchases in Genotech (066830), most recently on 2026-02-02. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Genotech have?
Genotech has 1 buy-side and 0 sell-side disclosures on record, covering ₩8M ($6K) in total reported value, spanning 2024-03-08 to 2026-02-02.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.